Every Cure and BioPhy launch partnership on drug repurposing
EveryCure will leverage BioLogicAI, BioPhy’s predictive AI engine, to assess drug-disease matches
Read more...
We're excited to announce our new partnership with Google Ventures, called Startup Sessions.
Hosted by Google Ventures and Vator, our newly-launched Startup Sessions is a monthly speaker series featuring one keynote speaker who will share his or her startup stories. The three-hour event, to be held at Google Ventures' Startup Lab, is designed to be a casual gathering of techies - entrepreneurs, developers, marketers, investors - who want to get the inside scoop about some of the highest-profile tech influencers.
Kicking off our series is David Sacks, CEO and founder of Yammer, which was bought by Microsoft for $1.2 billion this past June. Startup Sessions will be held on Oct. 16, from 5 pm to a little after 8 pm at Google Ventures' Startub Lab in Mountain View.
Want to join us? Register here. Tickets are only $35 and $100 gets you a demo table.
(Image source: dealtime.nytimes)
EveryCure will leverage BioLogicAI, BioPhy’s predictive AI engine, to assess drug-disease matches
Read more...The contract will make it easier for state agencies to evaluate and implement Fusion's technology
Read more...The new office marks OpenAI's first location in Asia
Read more...